arrow_back Civic Audit
Share share

Financial Aid for Drugs Must Count Towards Patient Deductibles and Copays.

This law requires health insurers to count financial assistance, such as grants from non-profits or drug manufacturer copay cards, directly toward a patient's annual cost-sharing requirements (deductibles, copayments, and out-of-pocket maximums). This change prevents insurers from using "copay accumulator" programs, ensuring that patients reach their annual spending limits faster, significantly lowering their overall healthcare costs, particularly for expensive specialty drugs. The provisions take effect starting January 1, 2026.
Key points
All financial assistance received for prescription drugs must be applied toward your deductible, copayment, and annual out-of-pocket maximum.
The rule specifically targets specialty drugs and drugs requiring utilization management (like prior authorization).
The law includes a safe harbor provision to ensure that High Deductible Health Plans (HDHPs) remain eligible for Health Savings Accounts (HSAs).
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_6423
Sponsor: Rep. Kean, Thomas H. [R-NJ-7]
Process start date: 2025-12-04